Certified by Founder
Lodge
TRIMTECH Therapeutics Limited
start up
United Kingdom
- Cambridge, England
- 07/03/2025
- Seed
- $31,000,000
TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs and TRIMGLUEs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
- Industry Biotechnology Research
- Website https://trimtechtherapeutics.com/
- LinkedIn https://www.linkedin.com/company/trimtech-therapeutics-limited/
Kubera Health | $6,500,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
Volt Harbor Inc. | $2,000,000 | (May 29, 2026)
Countable Labs | $26,000,000 | (May 29, 2026)
Solstice | $21,000,000 | (May 29, 2026)
Rep AI | $6,200,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Reactor | $59,000,000 | (May 29, 2026)
MokN | $15,000,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)
Blulabs | $7,000,000 | (May 29, 2026)
allO | $14,000,000 | (May 29, 2026)